We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.36B
AUM Growth
+$77.6M
Cap. Flow
+$46.1M
Cap. Flow %
3.39%
Top 10 Hldgs %
13.88%
Holding
1,633
New
514
Increased
325
Reduced
386
Closed
373

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$14.2M
2
DOMO icon
Domo
DOMO
+$12.7M
3
NFLX icon
Netflix
NFLX
+$12.4M
4
EA
Electronic Arts
EA
+$12.3M
5
DAY
Dayforce
DAY
+$11.5M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$17.1M
2
COOP
Mr. Cooper
COOP
+$13.5M
3
K
Kellanova
K
+$11.9M
4
LITE icon
Lumentum
LITE
+$9.69M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$9.44M

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Healthcare 13.54%
3 Communication Services 10.55%
4 Consumer Discretionary 9.61%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QIPT
1201
DELISTED
Quipt Home Medical
QIPT
$88.3K 0.01%
+25,000
New +$66.2K
JELD icon
1202
JELD-WEN Holding
JELD
$162M
$86.6K 0.01%
35,200
+11,459
+48% +$37.6K
INGN icon
1203
Inogen
INGN
$163M
$85.1K 0.01%
12,658
+2,600
+26% +$19.5K
LAC
1204
Lithium Americas
LAC
$1.18B
$84.8K 0.01%
+19,446
New +$112K
AMPY icon
1205
Amplify Energy
AMPY
$172M
$84.2K 0.01%
18,427
-15,841
-46% -$78.8K
NB
1206
NioCorp Developments
NB
$793M
$84.1K 0.01%
+15,861
New +$109K
OSG
1207
Octave Specialty Group
OSG
$210M
$82.8K 0.01%
10,643
-7,235
-40% -$61.8K
ARCO icon
1208
Arcos Dorados Holdings
ARCO
$1.7B
$82.4K 0.01%
11,228
-769
-6% -$5.54K
SEER icon
1209
Seer Inc
SEER
$119M
$80.6K 0.01%
44,052
-3,885
-8% -$7.92K
CLYM
1210
Climb Bio
CLYM
$778M
$79.7K 0.01%
19,918
-20,800
-51% -$49.9K
TMC icon
1211
TMC The Metals Company
TMC
$1.92B
$76.5K 0.01%
+12,393
New +$87K
IMMR icon
1212
Immersion
IMMR
$257M
$76.4K 0.01%
+11,233
New +$76.2K
QUAD icon
1213
Quad
QUAD
$507M
$75.1K 0.01%
11,984
+1,300
+12% +$7.65K
TE
1214
T1 Energy
TE
$1.48B
$74.8K 0.01%
+11,195
New +$49.4K
NEPH icon
1215
Nephros
NEPH
$47.6M
$74.1K 0.01%
+15,180
New +$77.6K
DGXX
1216
Digi Power X Inc
DGXX
$370M
$71.8K 0.01%
+28,174
New +$106K
YTRA icon
1217
Yatra Online
YTRA
$52.8M
$68.7K 0.01%
+38,598
New +$63.5K
CTKB icon
1218
Cytek Biosciences
CTKB
$606M
$67.7K 0.01%
+13,400
New +$62.2K
PTON icon
1219
Peloton Interactive
PTON
$2.42B
$66.9K ﹤0.01%
10,860
-9,562
-47% -$67.3K
ULBI icon
1220
Ultralife
ULBI
$116M
$66.6K ﹤0.01%
11,641
+1,200
+11% +$7.4K
AUTL
1221
Autolus Therapeutics
AUTL
$551M
$63.7K ﹤0.01%
32,008
-39,153
-55% -$60.2K
ISPO
1222
DELISTED
Inspirato
ISPO
$62.5K ﹤0.01%
+15,000
New +$44.4K
KAZR
1223
Skyline Builders Group
KAZR
$60.5M
$62.2K ﹤0.01%
21,167
-5,431
-20% -$16.3K
CLAR icon
1224
Clarus
CLAR
$145M
$61.8K ﹤0.01%
18,460
-2,100
-10% -$7.15K
ORMP icon
1225
Oramed Pharmaceuticals
ORMP
$175M
$61.6K ﹤0.01%
+21,613
New +$55.7K
47 48
49
50 51

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Prelude Capital Management held 1,633 positions worth $1.36B, up 6.1% from $1.28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management deployed $46.1M of net new capital in Q4 2025, opening 514 new positions and adding to 325 existing holdings. Its largest new stake was Nice: 117,600 shares worth $13.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Lumentum, an estimated $9.69M trimmed.

  • Prelude Capital Management's largest Q4 2025 buy was Nice: 117,600 shares worth $13.3M.
  • Prelude Capital Management added most to Domo in Q4 2025, an estimated $12.7M increase.
  • Prelude Capital Management's biggest Q4 2025 reduction was Lumentum, cutting an estimated $9.69M.
  • Prelude Capital Management fully exited Verona Pharma in Q4 2025, selling an estimated $17.1M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.36B portfolio in Q4 2025.
  • Prelude Capital Management opened 514 new positions and closed 373 in Q4 2025.
  • Prelude Capital Management's portfolio value rose 6.1% quarter-over-quarter to $1.36B.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.